METASTASIS CASTRATION RESISTANT PROSTATE CANCER(MCRPC)

Clinical trials for METASTASIS CASTRATION RESISTANT PROSTATE CANCER(MCRPC) explained in plain language.

Never miss a new study

Get alerted when new METASTASIS CASTRATION RESISTANT PROSTATE CANCER(MCRPC) trials appear

Sign up with your email to follow new studies for METASTASIS CASTRATION RESISTANT PROSTATE CANCER(MCRPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Smart scans may slash radiation doses for metastatic prostate cancer

Disease control Not yet recruiting

This early-phase trial explores whether PSMA PET scans can help doctors adjust radiation therapy for men with prostate cancer that has spread to 4 to 20 spots in the body. Participants receive standard hormone therapy plus a special PET scan, then targeted radiation to all visibl…

Matched conditions: METASTASIS CASTRATION RESISTANT PROSTATE CANCER(MCRPC)

Phase: EARLY_PHASE1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control

Last updated Jul 02, 2026 00:00 UTC

METASTASIS CASTRATION RESISTANT PROSTATE CANCER(MCRPC)

Get alerted when new METASTASIS CASTRATION RESISTANT PROSTATE CANCER(MCRPC) trials appear

Smart scans may slash radiation doses for metastatic prostate cancer